Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease.

• Authors: Alberto Fragasso, Clara Mannarella, Angela Ciancio, Agata Calvario, Maria Luisa Scarasciulli
• Journal: Leukemia & lymphoma (Leuk Lymphoma) Vol. 49 Issue 11 Pg. 2224-6 (Nov 2008) ISSN: 1029-2403 [Electronic] United States
• PMID: 19021070 (Publication Type: Case Reports, Letter)

Chemical References

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Murine-Derived
• Rituximab

Topics

• Aged
• Antibodies, Monoclonal (therapeutic use)
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Castleman Disease (drug therapy, virology)
• Herpesviridae Infections
• Herpesvirus 8, Human
• Humans
• Male
• Remission Induction
• Rituximab
• Treatment Outcome